medRxiv preprint doi: https://doi.org/10.1101/2020.05.15.20102863; this version posted May 20, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license . Estimating the cost-of-illness associated with the COVID-19 outbreak in China from January to March 2020 Huajie Jin*, Haiyin Wang*, Xiao Li, Weiwei Zheng, Shanke Ye, Sheng Zhang, Jiahui Zhou, Mark Pennington *Contributed equally King’s Health Economics, Institute of Psychiatry, Psychology & Neuroscience at King’s College London, London, UK (H Jin PhD, M Pennington PhD); Shanghai Health Development Research Centre, Shanghai, P.R. China (H Wang PhD); Centre for Health Economics Research & Modelling Infectious Diseases, University of Antwerp, Antwerp, Belgium (X Li MSc); Department of Environmental Health, School of Public Health, Fudan University, Shanghai City, P.R China (W Zheng PhD); Department of Infectious Disease, Shanghai Public Health Clinical Center, Shanghai, P.R. China (S Ye MD); Cancer Centre, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China (S Zhang MD); School of Population and Global Health, The University of Western Australia, Perth, Australia (J Zhou MPH). Correspondence to: Dr Huajie Jin, King’s Health Economics, Institute of Psychiatry, Psychology & Neuroscience at King’s College London, Box 024, The David Goldberg Centre, London, UK, SE5 8AF (
[email protected]) 1 NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.